バイオバンク機器の世界市場

バイオバンク機器の世界市場は2030年までに446億米ドルに達する

2024年に380億米ドルと推定されるバイオバンク機器の世界市場は、2024年から2030年にかけてCAGR 2.7%で成長し、2030年には446億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR 3.9%を記録し、分析期間終了時には189億米ドルに達すると予想されます。消耗品セグメントの成長率は、分析期間を通じてCAGR 1.7％と推定されます。

米国市場は104億米ドルと推定、中国はCAGR 5.3％で成長予測

米国のバイオバンク機器市場は、2024年に104億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに87億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と2.1%と予測されています。欧州では、ドイツがCAGR 1.5%で成長すると予測されています。

世界のバイオバンク機器市場- 主要動向と促進要因のまとめ

なぜバイオバンク機器が精密医療、生物医学研究、長期的な生物試料の完全性の中心的存在になりつつあるのか？

バイオバンク機器は、組織、血液、DNA、細胞培養などの生物試料の標準化された完全性の高い保存を可能にし、現代の生物試料保存のインフラ基盤を形成しています。バイオリポジトリの規模が拡大し、特にゲノム、腫瘍学、再生医療、臨床試験における戦略的関連性が高まるにつれ、信頼性が高く、拡張性があり、コンプライアンスに準拠したバイオバンキングシステムに対する需要が高まっています。冷凍庫、冷蔵庫、極低温タンク、サンプル管理ソフトウェア、自動ハンドリングシステムは、多様な検体の種類と保存期間にわたって、トレーサビリティ、生存性、品質管理を一括して保証します。

集団規模のバイオバンクや多施設共同研究の急増により、縦断的研究、実臨床エビデンスの作成、個別化治療モデルのサポートにおけるバイオバンク機器の重要性が高まっています。これらのシステムは、厳密に管理された温度、湿度、無菌条件下での生物試料の安全な保管と迅速な回収を可能にし、分子診断、バイオマーカーの検証、治療法の発見といった下流のアプリケーションに不可欠です。ライフサイエンスの研究開発がますますデータ主導型になるにつれ、検体の完全性とメタデータの正確性が、再現性とトランスレーショナルな関連性を実現する基盤として台頭してきています。

精密医療と世界ヘルスサーベイランスの台頭の中で、バイオバンクはもはや孤立した保管庫ではなく、研究、臨床、商業のワークフローに統合された戦略的資産となっています。バイオバンク機器は現在、運用効率の要件だけでなく、ISO 20387、FDA CFR 21 Part 11、GxPなどのガイドラインに基づく規制上の期待も満たさなければならないです。このような動きは、学術機関、政府機関、民間企業のバイオリポジトリにおいて、技術的に先進的で、監査が可能で、将来に備えた機器ソリューションへの需要を強めています。

自動化、コールドチェーン革新、デジタル統合はどのようにバイオバンク機器の機能を強化しているのか？

自動化は、手作業によるミスを減らし、スループットを向上させ、大量のサンプル在庫への24時間365日のアクセスを可能にすることで、バイオバンク業務を変革しています。ロボットによる保管と検索システム、自動ラベリング、バーコード/RFIDベースの追跡は、ばらつきを最小限に抑え、正確なサンプルの定位を保証します。これらの技術革新は、超低温安定性を維持しながら設置面積を最適化し、垂直またはモジュール式システムでの高密度保管をサポートします。自動化は、迅速でエラーのない処理が不可欠な、バイオ医薬品がスポンサーとなる臨床試験や大規模コホート研究において特に不可欠です。

低温保存技術の進歩により、機器の信頼性とエネルギー効率はさらに向上しています。通常-80℃で稼働する超低温フリーザー（ULT）は現在、低GWP冷媒、省エネルギーコンプレッサー、リアルタイム温度モニタリングで設計されています。幹細胞、胚、RNAサンプルの長期保存に使用される液体窒素ベースの極低温タンクには、真空断熱パネル、遠隔監視システム、フェイルセーフバックアップモジュールが組み込まれ、停電やシステム障害時にも保存が中断されないようになっています。

デジタル統合は包括的な生物試料のライフサイクル管理を可能にします。検査情報管理システム（LIMS）、クラウドベースのダッシュボード、IoT対応センサーが機器に組み込まれ、サンプルのメタデータを追跡し、機器の健全性を監視し、監査証跡を自動化します。ELN、臨床データベース、ブロックチェーンプラットフォームとの統合は、データの出所を確保し、施設間の連携を強化するソリューションとして浮上しています。相互運用性とデータの完全性が重要な差別化要因となる中、バイオバンク機器は、物理的サンプルとデジタルエコシステムをリアルタイムでリンクさせるコネクテッドプラットフォームへと進化しています。

バイオバンク機器の市場拡大を牽引しているエンドユーザーセグメント、地域投資、調達モデルは？

学術研究機関、製薬企業、病院ベースのバイオバンク、政府主導の集団調査が、バイオバンク機器の主要なエンドユーザーです。製薬会社やバイオテクノロジー企業は、創薬、コンパニオン診断、バイオマーカー主導の臨床開発をサポートするために、民間のバイオリポジトリに投資しています。受託研究機関（CRO）もまた、臨床試験のアウトソーシングにおける生物試料の保管とロジスティクスのニーズに対応するため、コールドチェーン機能を拡大しています。

北米は、NIHが支援するバイオバンク・ネットワーク、ゲノミクス・コンソーシアム、プレシジョン・メディシン・プログラムの普及によって世界市場をリードしています。欧州は、GDPRやISO規格に基づく規制の調和や、産学連携の拡大に牽引され、僅差で続いています。アジア太平洋は、中国、日本、韓国、インドなどの国々が国家バイオバンキングインフラ、ゲノムサーベイランス、トランスレーショナルヘルスプラットフォームに投資しており、高成長地域として浮上しています。こうした開発は、公的資金、民間投資、ヘルスケアのデジタル化とバイオメディカル・イノベーションに関する地域政府の指令によって支えられています。

調達戦略は、ソフトウェア、サービス契約、コンプライアンスサポートがバンドルされた統合機器スイートを好むように進化しています。バイヤーは、拡張性、遠隔診断、より広範なラボのITエコシステムとの互換性を提供する機器を優先する傾向が強まっています。リソースに制約のあるラボや新興バイオテクノロジー企業では、レンタルモデル、サービスとしての機器提供、複数年のサービス契約が人気を集めており、高額な初期資本支出なしにバイオバンキング機能を拡張できるようになっています。

バイオバンク機器市場の成長を促進する要因は何か？

バイオバンク機器市場は、生物試料の保存が現代の生物医学研究、治療開発、個別化ヘルスケアの提供にとってミッションクリティカルになるにつれて拡大しています。機器の技術革新により、生物学的材料や使用事例の拡大に伴い、高信頼性、拡張性、デジタル接続された保存が可能になりつつあります。

主な成長促進要因としては、大規模なバイオバンク構想の台頭、自動化とスマートモニタリングシステムの統合、規制に準拠したインフラに対する需要の高まり、ライフサイエンス研究開発における生物試料主導の洞察の価値の高まりなどが挙げられます。人口保健、精密腫瘍学、感染症サーベイランスへの地域的投資は、市場の勢いをさらに加速させています。

バイオバンクが受動的な保管ユニットから戦略的なデータ生成ハブへと移行する中、バイオバンク機器は次世代精密医療エコシステムにおける生物学的サンプル、実世界データ、デジタルヘルスプラットフォームの融合を可能にする技術的結節点となり得るだろうか。

セグメント

製品タイプ（装置、消耗品、ソフトウェア、サービス）、用途（再生医療、創薬・臨床研究、診断）、最終用途（製薬、バイオバンク、病院、受託研究機関、その他の最終用途）

調査対象企業の例（全34件）

• Azenta Life Sciences
• Becton, Dickinson and Company（BD）
• Bio-Techne Corporation
• Brooks Automation, Inc.
• Greiner Bio-One International GmbH
• Haier Biomedical
• Hamilton Company
• Harvard Bioscience, Inc.
• Izon Science Limited
• Lonza Group AG
• Merck KGaA
• Orcella Instruments
• Panasonic Healthcare Holdings Co., Ltd.
• PHC Holdings Corporation（PHCbi）
• Promega Corporation
• Qiagen N.V.
• Sartorius AG
• Standard BioTools Inc.
• Stemcell Technologies Inc.
• Tecan Group Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Biobanking Equipment Market to Reach US$44.6 Billion by 2030

The global market for Biobanking Equipment estimated at US$38.0 Billion in the year 2024, is expected to reach US$44.6 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$18.9 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.4 Billion While China is Forecast to Grow at 5.3% CAGR

The Biobanking Equipment market in the U.S. is estimated at US$10.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Biobanking Equipment Market - Key Trends & Drivers Summarized

Why Is Biobanking Equipment Becoming Central to Precision Medicine, Biomedical Research, and Long-Term Biospecimen Integrity?

Biobanking equipment forms the infrastructure backbone of modern biospecimen preservation, enabling standardized, high-integrity storage of biological materials such as tissues, blood, DNA, and cell cultures. As biorepositories grow in size and strategic relevance, especially within genomics, oncology, regenerative medicine, and clinical trials, the demand for reliable, scalable, and compliant biobanking systems is intensifying. Freezers, refrigerators, cryogenic tanks, sample management software, and automated handling systems collectively ensure traceability, viability, and quality control across diverse specimen types and storage durations.

The proliferation of population-scale biobanks and multi-center research collaborations has elevated the importance of biobanking equipment in supporting longitudinal studies, real-world evidence generation, and personalized treatment models. These systems enable the secure archiving and rapid retrieval of biospecimens under tightly controlled temperature, humidity, and sterility conditions-critical for downstream applications in molecular diagnostics, biomarker validation, and therapeutic discovery. As life science R&D becomes increasingly data-driven, specimen integrity and metadata accuracy are emerging as foundational enablers of reproducibility and translational relevance.

Amid the rise of precision medicine and global health surveillance, biobanks are no longer isolated storage units but strategic assets integrated into research, clinical, and commercial workflows. Biobanking equipment must now meet not only operational efficiency requirements but also regulatory expectations under guidelines such as ISO 20387, FDA CFR 21 Part 11, and GxP. These dynamics are reinforcing demand for technologically advanced, auditable, and future-ready equipment solutions across academic, government, and private sector biorepositories.

How Are Automation, Cold Chain Innovation, and Digital Integration Enhancing Biobanking Equipment Functionality?

Automation is transforming biobank operations by reducing manual handling errors, increasing throughput, and enabling 24/7 access to high-volume sample inventories. Robotic storage and retrieval systems, automated labeling, and barcode/RFID-based tracking are minimizing variability and ensuring precise sample localization. These innovations support high-density storage in vertical or modular systems, optimizing footprint while maintaining ultra-low temperature stability. Automation is particularly vital in biopharma-sponsored trials and large-scale cohort studies where rapid, error-free processing is essential.

Advancements in cold storage technologies are further enhancing equipment reliability and energy efficiency. Ultra-low temperature freezers (ULTs), typically operating at -80°C, are now being designed with low-GWP refrigerants, energy-saving compressors, and real-time temperature monitoring. Liquid nitrogen-based cryogenic tanks-used for long-term preservation of stem cells, embryos, and RNA samples-are incorporating vacuum-insulated panels, remote monitoring systems, and fail-safe backup modules to ensure uninterrupted storage during power outages or system failures.

Digital integration is enabling comprehensive biospecimen lifecycle management. Laboratory information management systems (LIMS), cloud-based dashboards, and IoT-enabled sensors are being embedded into equipment to track sample metadata, monitor equipment health, and automate audit trails. Integration with ELNs, clinical databases, and blockchain platforms is emerging as a solution to secure data provenance and enhance cross-institutional collaboration. As interoperability and data integrity become critical differentiators, biobanking equipment is evolving into connected platforms that link physical samples with digital ecosystems in real time.

Which End-User Segments, Regional Investments, and Procurement Models Are Driving Market Expansion for Biobanking Equipment?

Academic research institutions, pharmaceutical companies, hospital-based biobanks, and government-led population studies represent the primary end-user base for biobanking equipment. Pharmaceutical and biotech firms are investing in private biorepositories to support drug discovery, companion diagnostics, and biomarker-driven clinical development. Contract research organizations (CROs) are also expanding cold-chain capabilities to meet the biospecimen storage and logistics needs of outsourced clinical trials.

North America leads the global market, anchored by NIH-supported biobank networks, genomics consortia, and widespread adoption of precision medicine programs. Europe follows closely, driven by regulatory harmonization under GDPR and ISO standards, alongside growing academic-industry partnerships. Asia-Pacific is emerging as a high-growth region with countries like China, Japan, South Korea, and India investing in national biobanking infrastructure, genomic surveillance, and translational health platforms. These developments are supported by public funding, private investments, and regional government mandates around healthcare digitization and biomedical innovation.

Procurement strategies are evolving to favor integrated equipment suites bundled with software, service contracts, and compliance support. Buyers are increasingly prioritizing equipment that offers scalability, remote diagnostics, and compatibility with broader laboratory IT ecosystems. Rental models, equipment-as-a-service offerings, and multi-year service agreements are gaining traction among resource-constrained labs and startup biotechs, allowing them to scale biobanking capabilities without high upfront capital expenditure.

What Are the Factors Driving Growth in the Biobanking Equipment Market?

The biobanking equipment market is expanding as biospecimen preservation becomes mission-critical to modern biomedical research, therapeutic development, and personalized healthcare delivery. Equipment innovation is enabling high-integrity, scalable, and digitally connected storage across a growing spectrum of biological materials and use cases.

Key growth drivers include the rise of large-scale biobanking initiatives, integration of automation and smart monitoring systems, increasing demand for regulatory-compliant infrastructure, and the growing value of biospecimen-driven insights in life sciences R&D. Regional investments in population health, precision oncology, and infectious disease surveillance are further amplifying market momentum.

As biobanks transition from passive storage units to strategic data-generating hubs, could biobanking equipment become the technological nexus enabling the convergence of biological samples, real-world data, and digital health platforms in next-generation precision medicine ecosystems?

SCOPE OF STUDY:

The report analyzes the Biobanking Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Equipment, Consumables, Software, Services); Application (Regenerative Medicine, Drug Discovery & Clinical Research, Diagnostics); End-Use (Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Azenta Life Sciences
• Becton, Dickinson and Company (BD)
• Bio-Techne Corporation
• Brooks Automation, Inc.
• Greiner Bio-One International GmbH
• Haier Biomedical
• Hamilton Company
• Harvard Bioscience, Inc.
• Izon Science Limited
• Lonza Group AG
• Merck KGaA
• Orcella Instruments
• Panasonic Healthcare Holdings Co., Ltd.
• PHC Holdings Corporation (PHCbi)
• Promega Corporation
• Qiagen N.V.
• Sartorius AG
• Standard BioTools Inc.
• Stemcell Technologies Inc.
• Tecan Group Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biobanking Equipment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Biospecimen Preservation in Genomic and Clinical Research Throws the Spotlight on Biobanking Equipment
  • Growth in Personalized Medicine and Cancer Biorepositories Spurs Investment in Long-Term Cryogenic Storage
  • OEM Innovation in Ultra-Low Temperature Freezers and Automated Sample Handling Enhances Sample Integrity
  • Expansion of Cell and Gene Therapy Trials Supports Need for High-Capacity, GMP-Compliant Storage Systems
  • Integration of RFID, Barcode, and Biometric Access Controls Enhances Inventory Accuracy and Data Traceability
  • Growth in Population-Based Biobanks and Epidemiological Studies Fuels Demand for Scalable Storage Infrastructure
  • Rising Focus on Quality Control and Audit Readiness Drives Demand for Temperature Mapping and Alarm Systems
  • Use in Forensics, Transplant, and Regenerative Medicine Expands Biobank Application Scope
  • Adoption of Green Cooling Technologies and Energy-Efficient ULT Freezers Aligns With Sustainability Targets
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Biobanking Equipment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Drug Discovery & Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• JAPAN
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• CHINA
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• EUROPE
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Biobanking Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• FRANCE
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• GERMANY
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Biobanking Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• INDIA
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Biobanking Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Biobanking Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
• AFRICA
  • Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030

IV. COMPETITION